Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma

NCT00002882 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Skin Cancer

Interventions

BIOLOGICAL: Aldesleukin (IL-2)
BIOLOGICAL: Recombinant Interferon Alfa (IFN-A)
DRUG: Cisplatin
DRUG: Dacarbazine
DRUG: Vinblastine
PROCEDURE: Adjuvant Therapy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]